La Jolla Pharmaceutical's (LJPC) "Buy" Rating Reiterated at Cowen


's stock had its "buy" rating reiterated by analysts at Cowen in a report issued on Friday. They currently have a $55.00 target price on the biopharmaceutical company's stock.



from Biotech News